Verona Pharma plc buy HC Wainwright
Start price
21.01.25
/
50%
€0.51
Target price
21.01.26
€57.80
Performance (%)
-
End price
22.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | -0.479% | -12.062% | -2.949% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 9.585% |
| iShares Nikkei 225® | -0.143% | -12.633% | 20.316% |
| iShares S&P 500 | -2.266% | -5.049% | 5.803% |
Comments by HC_Wainwright for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock, up previously from $42.00.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten